AUTHOR NAME

Myles

7 POSTS
0 COMMENTS

TauRx Pharmaceuticals Submits UK Marketing Authorisation Application for Alzheimer’s Treatment

TauRx Pharmaceuticals Ltd, has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM). This drug is intended for the...

Waypoint Bio Secures $14.5 Million in Seed Funding to Advance Cell Therapies for Solid Tumors

Waypoint Bio, a biotechnology company innovating cell therapies for solid tumors through in vivo spatial pooled screening technology, has announced the successful acquisition of...

BioMérieux’s New BIOFIRE® SPOTFIRE® R/ST Panel Mini Gains FDA Clearance and CLIA-Waiver

BioMérieux, a global leader in in vitro diagnostics, has announced that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received Special 510(k) clearance...

Unveiling the Hidden Genomic Influences on Human Traits: A Breakthrough in Copy Number Variation Analysis

The realm of human genetics is continuously evolving, with each discovery pushing the boundaries of our understanding. One area that has intrigued scientists for...

The AI Revolution in Drug Discovery: Early Evidence and Implications

Drug discovery has long been an arduous journey, marked by high costs, extensive timelines, and significant uncertainty. Despite the latest experimental technologies, many discovery...

Athos Therapeutics Selects Vultr Cloud GPU for Advanced AI Model Training and Inference

Vultr, the world's largest privately-held cloud computing platform, proudly announces that Athos Therapeutics, Inc. ("Athos"), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU...

Delve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections

Delve Bio and UCSF Unveil Pioneering mNGS Study at American Society of Microbiology Microbe Conference Delve Bio, a leader in metagenomic next-generation sequencing (mNGS) for...

Latest news